Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Evaluation of the OtoSight

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03890107
Recruitment Status : Active, not recruiting
First Posted : March 26, 2019
Last Update Posted : July 14, 2021
Sponsor:
Collaborators:
Carle Foundation Hospital
Children's National Health System
National Institute on Deafness and Other Communication Disorders (NIDCD)
Information provided by (Responsible Party):
PhotoniCare, Inc.

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The objective of this study is to evaluate the imaging capabilities and image analysis performance of the OtoSight Middle Ear Scope in pediatric patients undergoing tympanostomy tube placement for otitis media. In this observational study, results of OtoSight imaging will not affect patient standard of care.

Condition or disease Intervention/treatment
Otitis Media Device: OtoSight Middle Ear Scope

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Actual Enrollment : 110 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Clinical Evaluation of a New Middle Ear Diagnostic to Support FDA Regulatory Clearance
Actual Study Start Date : April 15, 2019
Actual Primary Completion Date : April 30, 2021
Estimated Study Completion Date : August 27, 2021

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Ear Infections

Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort Intervention/treatment
Pediatric tympanostomy tube patients
Patients diagnosed with otitis media and scheduled for tympanostomy tube placement will be imaged with the OtoSight
 Device: OtoSight Middle Ear Scope
OtoSight imaging using a near-infrared laser


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. OtoSight imaging exam [ Time Frame: 1-5 minutes ]
    Optical coherence tomography imaging to evaluate the middle ear.


Secondary Outcome Measures :
  1. Adverse events [ Time Frame: Date of recruitment (day of surgery) to post-operative follow-up visit (approx. 1 month, but can be longer) ]
    Rate of adverse events


Biospecimen Retention:   Samples With DNA
Middle ear effusion, if present

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   up to 17 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Children diagnosed with otitis media and scheduled for tympanostomy tube surgery.
Criteria

Inclusion Criteria:

  • Children (17 years old or younger) scheduled for tympanostomy tube placement

Exclusion Criteria:

  • Otoscopy contra-indicated or not possible per attending physician's decision
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03890107


Locations
Layout table for location information
United States, District of Columbia
Children's National Health System
Washington, District of Columbia, United States, 20010
United States, Illinois
Carle Foundation Hospital
Urbana, Illinois, United States, 61801
Sponsors and Collaborators
PhotoniCare, Inc.
Carle Foundation Hospital
Children's National Health System
National Institute on Deafness and Other Communication Disorders (NIDCD)
Investigators
Layout table for investigator information
Principal Investigator: Ryan Shelton, PhD PhotoniCare, Inc.
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: PhotoniCare, Inc.
ClinicalTrials.gov Identifier: NCT03890107    
Other Study ID Numbers: 000001
R44DC014599 ( U.S. NIH Grant/Contract )
First Posted: March 26, 2019    Key Record Dates
Last Update Posted: July 14, 2021
Last Verified: May 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: Yes
Device Product Not Approved or Cleared by U.S. FDA: Yes
Product Manufactured in and Exported from the U.S.: No
Keywords provided by PhotoniCare, Inc.:
Ear Infection
Ear tubes
Myringotomy
Otitis Media
Tympanostomy
Additional relevant MeSH terms:
Layout table for MeSH terms
Otitis
Otitis Media
Ear Diseases
Otorhinolaryngologic Diseases